Comparison of Pemetrexed and Docetaxel as Salvage Chemotherapy for the Treatment of Non-Small-Cell Lung Cancer After the Failure of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

January 2014 in “ Journal of international medical research ”

Dong Li, Zhaofeng Han, Zihui Feng, Zhiyang Jia

TLDR Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

In a Phase 2 trial with 109 NSCLC patients who failed EGFR-TKI therapy, pemetrexed and docetaxel were compared as salvage chemotherapy. Both treatments showed no significant differences in disease control rate, response rate, median survival, or 1-year survival. However, docetaxel caused higher rates of nausea, myelosuppression, renal damage, and hair loss. Pemetrexed was found to be effective and better tolerated, making it a suitable option for salvage chemotherapy in these patients.

View this study on journals.sagepub.com →

Discuss this study in the Community →

Similar Research

6 / 1000+ results

research Towards a Molecular Understanding of Hair Loss and Its Treatment

236 citations, July 2001 in “Trends in Molecular Medicine”

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

research Female Pattern Hair Loss

226 citations, September 2001 in “Journal of The American Academy of Dermatology”

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

research A Randomized, Placebo-Controlled Trial of 5% and 2% Topical Minoxidil Solutions in the Treatment of Female Pattern Hair Loss

219 citations, March 2004 in “Journal of The American Academy of Dermatology”

5% and 2% minoxidil solutions effectively promote hair growth and reduce hair loss, with 5% being slightly more effective but having more side effects.

The Importance of Dual 5α-Reductase Inhibition in the Treatment of Male Pattern Hair Loss: Results of a Randomized Placebo-Controlled Study of Dutasteride Versus Finasteride

research The Importance of Dual 5α-Reductase Inhibition in the Treatment of Male Pattern Hair Loss: Results of a Randomized Placebo-Controlled Study of Dutasteride Versus Finasteride

215 citations, November 2006 in “Journal of The American Academy of Dermatology”

Dutasteride more effective for hair growth, but has more side effects than finasteride.

research The Diagnosis and Treatment of Iron Deficiency and Its Potential Relationship to Hair Loss

207 citations, April 2006 in “Journal of The American Academy of Dermatology”

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

research Prevalence of Male and Female Pattern Hair Loss in Maryborough

193 citations, August 2005 in “Journal of Investigative Dermatology Symposium Proceedings”

Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.

Comparison of Pemetrexed and Docetaxel as Salvage Chemotherapy for the Treatment of Non-Small-Cell Lung Cancer After the Failure of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

Related Community Posts Join

community Hair Loss Inflammation Prevention Stack

community People who moan that more important things than hair loss treatment should be researched need to shut the

community Hair loss progress after 1 year of min and 7 months fin

community Does anyone think their hair loss is thyroid related?

community Hair Loss & Lipids: Why you have sebderm, folliculitis, LPP, inflammation, etc...

community I understand this topic has been discussed countless times, but hair loss is the most brutal experience for men.